Navigation Links
Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
Date:10/2/2008

and treatment of CVD. The company was founded in 2002 to exploit findings made by Professors Johan Frostegard and Ulf de Faire on the critical role of phospholipid antibodies (aPL) in the inflammatory process of cardiovascular disease. Athera is based in Karolinska Institutet Science Park in Stockholm and main investors include Karolinska Development and Baltic Sea Foundation. Athera is a major partner in the highly ranked EU-project CVDIMMUNE lead by Karolinska Institutet. The project involves 10 academic and industrial partners, including Phadia GmbH, Johannes Gutenberg-University Mainz and Leiden University Medical Center. For further information see http://www.athera.se.

Contact: Carina Schmidt, CEO, Phone: +46705525115, Mail: c.schmidt@athera.se


'/>"/>
SOURCE Athera Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
2. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  Alimera Sciences, Inc. (NASDAQ: ALIM ) ... development and commercialization of prescription ophthalmic pharmaceuticals, announced today ... Hercules Technology Growth Capital, Inc. (NYSE: HTGC ... advance under the Loan and Security Agreement that Alimera,s ... Alimera Sciences Limited, entered into with Hercules in April ...
(Date:9/30/2014)... , Sept. 30, 2014 The Chinese ... ageing population and rise in the incidence of lifestyle ... wounds and in affordability of better quality of wound ... care market. Universal coverage of public health insurance schemes ... further stimulate demand. Based on the findings of primary ...
(Date:9/30/2014)... 30, 2014  HealthLoop® released an app version of ... iOS 8 and allows people to share medical device ... native iOS technologies to enhance the HealthLoop experience for ... with their doctors between visits. "This ... they collect is exciting," says HealthLoop founder Dr. ...
Breaking Medicine Technology:Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2China Wound Care Market 2China Wound Care Market 3HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2
... Sept. 18 ,Interleukin Genetics, Inc. (Amex: ILI ... collaboration to explore the role of genetics in,obesity. ... a series of genetic,tests that will help physicians ... and, more specifically, gauge a patient,s,likelihood of success ...
... VRUS ) management will present at the UBS ... at the Grand Hyatt Hotel,in New York City. Schaefer ... the company on Wednesday, September 24, 2008,from 4:00 PM ... webcast of Mr. Price,s overview via the internet, log,on ...
Cached Medicine Technology:Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success 2Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success 3Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th 2
(Date:9/30/2014)... standards to cut climate-changing carbon emissions will reduce ... health benefits, according to a new study released ... policy options included in the final Clean Power ... of premature deaths and hospitalizations, and hundreds of ... In the new study, Health Co-benefits of Carbon ...
(Date:9/30/2014)... R.I. [Brown University] Autism is no stranger to ... East African nation is access to clinical services, including ... diagnostic measure, for example, validated for use in Swahili, ... new study, however, researchers at Brown University and the ... approach that they implemented at two sites in the ...
(Date:9/30/2014)... Integrated Medicine Alliance , Monmouth County’s ... medical specialty practice through a unique partnership with an ... located within the company’s Shrewsbury location and will be ... of American Heart Center, P.C., a highly regarded practice ... Integrated Medicine Alliance patients top notch cardiovascular care without ...
(Date:9/30/2014)... Las Vegas, NV (PRWEB) September 30, 2014 ... released by Blue Star Nutraceuticals designed to help maximize ... ingredients that optimizes the body’s absorption of glucose has ... review. , “The main purpose behind Glycodrive is ... that builds lean muscle,” reports Michaels. “Carbs are essential ...
(Date:9/30/2014)... VisitandCare.com reports that revenue for ... more than 79 percent in 2014, marking five straight ... total revenue tripled for its entirety of partnered medical ... has allowed them to partner with plastic surgery ... and privacy — with state-of-the-art surgical atmospheres aimed to ...
Breaking Medicine News(10 mins):Health News:Power plant standards could save thousands of US lives every year 2Health News:Power plant standards could save thousands of US lives every year 3Health News:New diagnostic approach for autism in Tanzania 2Health News:New diagnostic approach for autism in Tanzania 3Health News:New diagnostic approach for autism in Tanzania 4Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4
... of Rheumatology (ACR) is proposing a new set of diagnostic ... sleep disturbances, and cognitive problems, as well as pain. The ... ACR journal Arthritis Care & Research . "These ... pain," said Robert S. Katz, one of the authors of ...
... ... ... million adults have been diagnosed with some form of arthritis, according to the Arthritis ... and limited movement. Many sufferers have reported a reduced quality life with limited activity ...
... ... are all endangering our Planet. Thus many businesses are now employing Green Practices in ... environmentally friendly printing featuring high-quality recycled and chlorine-free papers at affordable prices., , ... Tempe, AZ (PRWEB) May ...
... ... Surgery , ... Phoenix, Ariz. (Vocus) May 24, 2010 -- Patients are traveling to Phoenix from far ... by Dr. Jimmy Chow, M.D. at St. Luke’s Medical Center . ...
... Neuralstem, Inc. (NYSE Amex: CUR) updated the progress ... ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig,s disease) at Emory ... reviewing the safety data from the first cohort of three ... next cohort and transplantation of the fourth patient. The ...
... United States, Canada lagging behind other developed countries, study ... death rate for children under the age of 5 ... as 800,000 fewer deaths -- than the latest mortality ... numbers gleaned from number-crunching conducted by researchers at the ...
Cached Medicine News:Health News:New criteria proposed for diagnosing fibromyalgia 2Health News:New criteria proposed for diagnosing fibromyalgia 3Health News:Massage Envy Provides Effective Way to Manage Arthritis Pain 2Health News:4 Color Flyers - Go Green Initiative 2Health News:4 Color Flyers - Go Green Initiative 3Health News:Arizona Surgeon Performs Hip Replacement Surgery with Fast Recovery, Less Pain 2Health News:Arizona Surgeon Performs Hip Replacement Surgery with Fast Recovery, Less Pain 3Health News:Global Death Rate for Children Lower Than Thought 2
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff.Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Sterile...
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. X-ray opaque line. Graduated. Single use. S...
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Graduat...
... of Topical Anesthetic, ,Designed for ... tube incorporates an additional lumen and ... topical anesthetic above and below the ... tubes designs which allow for CO2 ...
Medicine Products: